About OncoGenex



OncoGenex Announces Reduction in Force to Extend Cash Runway and Align Operations with Clinical Development Priorities

Thursday, Feb 4 2016

OncoGenex Announces Update on Phase 2 Spruce Trial in Previously Untreated Metastatic Non-Small Cell Lung Cancer

Wednesday, Jan 20 2016

OncoGenex Announces Apatorsen Phase 2 Borealis-2 Trial Continues Following Successful Completion of Futility Analysis

Wednesday, Dec 9 2015

OncoGenex Announces Phase 3 AFFINITY Trial with Custirsen Continues Following Interim Analyses

Tuesday, Dec 1 2015

OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Third Quarter 2015

Thursday, Nov 12 2015

OncoGenex Pharmaceuticals to Present at the Stifel 2015 Healthcare Conference

Thursday, Nov 5 2015

OncoGenex to Report Third Quarter 2015 Financial Results on November 12, 2015

Thursday, Oct 29 2015


External Link Pop Up Window

You are now exiting the OncoGenex Web site and entering a third party Web site.

OncoGenex does not review the information contained on the following Web site for content, accuracy or completeness. Use of and access to the information are subject to the terms, limitations and conditions set by the Web site producer. OncoGenex makes no claims about the accuracy or any other aspect of the information contained on this Web site, nor does OncoGenex necessarily endorse this Web site.

Stay on OncoGenex Continue